NGR015: Study in Second Line for Patient With Advanced Malignant Pleural Mesothelioma Pretreated With Pemetrexed
Status:
Completed
Trial end date:
2017-12-01
Target enrollment:
Participant gender:
Summary
The main objective of the trial is to document the efficacy of NGR-hTNF administered at low
dose weekly in advanced Malignant Pleural Mesothelioma patients previously treated with a
pemetrexed-based chemotherapy regimen.